Monitoring chronic heart failure through free speech into a smartphone app. It uses a multi-layer voice analysis workflow indicating changes in chronic heart failure patients' lung-fluids anatomy. And also has a smartphone app and proprietary algorithms that allow near real-time monitoring of patients. The company was founded in 2013 and headquartered in Or Yehuda, Israel. It has raised $18M in series a funding, with backing from Incentive Incubator, Ceros Capital Markets, Peregrine Ventures, Pix Vine Capital, and others. The company operates in the HealthTech - Disease Self Management, HealthTech - Healthcare IT, High Tech - Wearable Technology space. Its offerings span Wearable Technology - Health and Wellness Devices - Cardiac and Healthcare IT - Value Based Care - Remote Mon.
Cordio Medical
Series AMonitoring chronic heart failure through free speech into a smartphone app. It uses a multi-layer voice analysis workflow indicating changes in chronic heart failure patients' lung-fluids anatomy. And also has a smartphone app and proprietary algorithms that allow near real-time monitoring of patients. The company was founded in 2013 and headquartered in Or Yehuda, Israel. It has raised $18M in series a funding,…
About
Business model
Wearable Technology > Health and Wellness Devices > Cardiac,
Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > App,
Healthcare IT > Value Based Care > Remote Monitoring > Platforms > Speech Analysis
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Backed by funds in our directory
🗂️ Full list of active funds — filter by stage, check size, and geography.